Citius Oncology
Price & Volume
Stats
See moreOpen | $0.81 |
Previous Close | $0.81 |
Day Range | $0.81-$0.82 |
52W Range | $0.49-$2.25 |
Market Cap | $79.3M |
Shares Short | 399,412 |
Financials
See moreRevenue (12 Mos) | $7.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $5.3M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 10 days ago
Citius Oncology shares tumble as Q3 revenue misses forecasts despite LYMPHIR launch momentum
Yahoo Finance • 4 months ago
Citius raises $36.5m for Lymphir commercialisation
Yahoo Finance • 9 months ago
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
Yahoo Finance • 9 months ago
Citius Oncology rises after U.S. launch of Lymphir as a cancer treatment
About
CEO | Mr. Leonard L. Mazur |
Address | 11 Commerce Drive, Cranford, NJ, United States, 07016 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 0 |